Zydus Lifesciences Ltd.

BSE: 532321 | NSE: ZYDUSLIFE
Mid Cap | Pharmaceuticals & Drugs
936.35
-6.20 (-0.66%)
< Home < Back

Zydus Lifesciences informs about post results conference call

Date: 16-05-2022

Zydus Lifesciences has informed that the financial results of the company for Q4 2021-22 (January-March 2022) would be declared on May 20, 2022. Post results Q&A session through webinar (powered by Zoom) has been scheduled on the same day- May 20, 2022 at 5:00 pm. Sharvil Patel, Managing Director of the Company would be hosting the call and the details to join the call is provided in the attached file.

The above information is a part of company’s filings submitted to BSE.